June 20th 2025
Trendy manicures like Russian nails and 3D art may complicate diagnosis or cause damage, making them important for dermatologists to recognize.
Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient
July 26, 2025
Register Now!
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis
View More
Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?
View More
Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management
View More
Burst CME: Targeted Therapy for Optimal Psoriasis Management
View More
Going cosmetic? Start small—commit big
April 11th 2005New Orleans — The biggest mistake most dermatologists make when they decide to start a cosmetic dermatology practice is trying to jump into things too fast. That's the message Joel Schlessinger, M.D., a successful cosmetic dermatologist from Omaha, Neb., likes to share with his colleagues who are considering that move.
Multiple principles underlie safe, effective PIH tx
April 10th 2005San Diego — Post-inflammatory hyperpigmentation (PIH) is a common complaint among skin of color patients and one that is important to manage effectively because it can be a source of significant psychosocial distress, said Patricia Dunwell, M.D., at the Annual Meeting of the American Academy of Cosmetic Surgery (AACS).
Single session Botox safe, effective
April 1st 2005New Orleans — Botulinum toxin type A (Botox, Botox Cosmetic; Allergan) can be used safely and effectively in a range of doses to simultaneously treat a spectrum of upper facial rhytids in adult women, although use of a higher dose affords benefits for improved magnitude and durability of response without compromising safety, according to the results of a dose-comparison study presented by Alastair Carruthers, M.D., and Jean Carruthers, M.D., at the 63rd Annual Meeting of the American Academy of Dermatology (AAD).
Use of poly-L-lactic acid shows promise as treatment for lipodystrophic facial aging
April 1st 2005New Orleans — Initial clinical experience indicates injectable poly-L-lactic acid (Sculptra) can be used safely and effectively to achieve natural-appearing restoration of facial volume and contour in patients with age-related facial lipodystrophy, said Douglas Key, M.D., at the 63rd Annual Meeting of the American Academy of Dermatology (AAD) here.
Derm projects range of HA products will provide toolsfor lunchtime filling
April 1st 2005Boston — Although, for many patients, hyaluronic acid (HA) fillers have become the treatment of choice in the United States, Gary D. Monheit, M.D., says many questions remain: Can Hylaform (Inamed), Restylane (Q-Med) and Juvederm (LEA Derm) be improved to achieve more than a three- to six-month longevity? How will the fillers compare after more extensive head-to-head testing? And where will HA products ultimately fit in an armamentarium ranging from bovine collagen to polylactic acid?
New cosmetic laser technology emerges; noninvasive treatment rejuvenates skin
April 1st 2005New Orleans — A striking array of new, non-invasive cosmetic laser treatments and devices has been developed recently to help dermatologists rejuvenate skin and improve appearance. From class 2 products that treat cellulite to a variety of radiofrequency devices, the many options may leave physicians wondering which one to choose.
Alternative treatments for alopecia areata
April 1st 2005Florence — Alopecia areata is a disease with important aesthetic implications that may affect the patient psychologically and socially, and treatment can be challenging, according to Ana Kaminsky, M.D., Ph.D., professor of dermatology, School of Medicine, University of Buenos Aires, Argentina.
Vanity tax: Does it restrict choice?
April 1st 2005National report — A new precedent has been set in the cosmetic surgery industry, but it has nothing to do with surgical results. In September, New Jersey became the first state to enact a vanity tax on cosmetic surgery and Botox injections — a move that lawmakers elsewhere are now seeking to emulate, potentially leaving physicians and their patients at a loss.
Growth in cosmetic procedures signals shift
April 1st 2005National report — With the number of cosmetic procedures performed nationally rising, the line between dermatology and plastic surgery continues to blur as dermatologists devote more time to cosmetic procedures and plastic surgeons embrace less-invasive treatments.
The Expanding Role of 5-FU in Dermatology (PDF)
April 1st 2005Recently, a group of leading dermatologists, clinical investigators, and dermasurgeons met to discuss the role of 5-fluorouracil (5-FU) in their practices. The experts discussed a new treatment paradigm for actinic keratosis (AK) and how it is changing. They also shared their personal experiences in using 5-FU innovatively to treat AK, while reducing inflammation and discomfort and improving compliance. In addition, the physicians reviewed the use of 5-FU in the treatment of several other dermatologic conditions, such aswarts and actinic cheilitis.
Drug combination trumps single-agent acne treatment
March 1st 2005New Orleans — Combining a popular topical retinoid with a widely used antibiotic — and applying them at the same time as if they were one drug — clearly outperforms using either agent separately in treating acne, according to new data presented at the 63rd Annual Meeting of the American Academy of Dermatology (AAD) here.
Drug combination trumps single-agent acne treatment
February 21st 2005Combining a popular topical retinoid with a widely used antibiotic - and applying them at the same time as if they were one drug - clearly outperforms using either agent separately in treating acne. The key is adding to them a novel aqueous hydrogel which solubilizes the two old stand-by drugs and stabilizes them to provide a particularly effective once-daily treatment.
Silicone scar sheets minimize scar formation
February 20th 2005Silicone sheet technology has been clinically proven to improve the appearance of scars significantly and has been used by physicians for years, according to Pfizer who is displaying its Neosporin Scar Sheets here at the 63rd Annual Meeting.